• Information for Suppliers

    Quality Assurance Policy for Diagnostics Products amended in February 2014

    • QA Policy for Diagnostics Products QA Policy for Diagnostic Products (“QA policy”) as issued on 14 December 2010 amended in February 2014  
    • Invitation to manufacturers of Diagnostic Technologies for HIV Early Infant Diagnosis to submit an Expression of Interest (EoI) for product evaluation by an Expert Review Panel for Diagnostics (ERPD)   
      Submission deadline: 8 April 2014 

    Click here for details.

    Quality Assurance Policy for Pharmaceutical Products

    Quality Control Drug Testing Laboratory for Global Fund quality monitoring activities

    Questionnaire on the technical proficiency of QC Drug Testing Laboratories
    download [ DOC - 205 KBEnglish ]

    We are using this information to provide PRs with a List of QC [ XLSX - 90 KBEnglish ] Laboratories meeting Global Fund requirements, along with a list of WHO-prequalified laboratories who have responded to the questionnaire.

    Voluntary Pooled Procurement

    VPP procures through two procurement agents which were competitively selected. The Partnership for Supply Chain Management (PFSCM) procures ARVs; ACTs; rapid diagnostic tests for HIV and malaria; and IRS – and IDA Foundation procures LLINs and other health products: